Once daily versus three times daily mesalazine granules in active ulcerative colitis: a double-blind, double-dummy, randomised, non-inferiority trial.

Gut · 2009 · PMC3269751 · PMID 18832520

Europe PMC DOI

hedged sentence

0.0001

closest p · 0.0× alpha

0.0001

boldest claim

The sentences

highly significantp<0.0001actually significant

Therefore, non-inferiority between the OD and TID group was concluded with a highly significant p value (p<0.0001) and a very tight 95% CI for the difference between both treatment groups (3.4% (−5.0% to 11.8%)).

also in 132,142 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.